Ascidian Therapeutics Alternatives & Competitors
12 companies similar to Ascidian Therapeutics — Rewriting RNA
Companies similar to Ascidian Therapeutics
ReNAgade Therapeutics
RNA Without Limits
Cambridge, United States
Wave Life Sciences
Unlocking the broad potential of RNA medicines to transform human health
Cambridge, United States
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
San Diego, United States
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Rival Readout
Competing with Ascidian Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Elixirgen Therapeutics, Inc.
Reimagine the Power of RNA
Baltimore, United States
Rampart Bioscience
Leading a new era of effective, safe and accessible gene medicines.
Monrovia, United States
Avidity Biosciences, Inc.
At Avidity, we are developing a new class of oligonucleotide-based therapies.
San Diego, United States
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
United Kingdom
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Laronde
Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA)
Cambridge, United States
Alltrna
The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeu...
Cambridge, United States
About Ascidian Therapeutics
Ascidian Therapeutics, founded in 2020, is a pioneering company in the Biotechnology and Health and Wellness industries, headquartered in the United States. Their slogan, "Rewriting RNA," encapsulates their innovative approach to disease treatment by focusing on RNA editing. By targeting exons at the RNA level, they fa...
RNA exon editing platform, Developing RNA-based medicines, Manufacturing partnership for RNA therapies
Patients with genetic diseases, Healthcare professionals, Biotechnology researchers
RNA Therapeutics, Gene Editing, Post-transcriptional Editing, Ophthalmology, Neurological Disorders, Neuromuscular Disorders, Rare Diseases, Functional Proteins, Exon Editing, Disease Treatment, Precision Medicine, Preclinical Programs, Therapeutic Innovation
B2B, B2D
Licensing, Performance Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ascidian Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Ascidian Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
